Paediatrica  2002 4(3): 16-32

 

DERMATITIS ATÓPICA


BIBLIOGRAFÍA

1. Kay J et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30: 35-39.

2. Sugiura H et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population. Comparison with the disease frequency examines twenty years ago. Acta Der Venereol 1998; 78: 293-294.

3. Shultz F et al. The occurrence of atopic dermatitis in North Europe. An international questionnaire study. J Am Acad Dermatol 1996; 34: 760-764.

4. Rothe M et al. Atopic dermatitis: an update. J Am Acad Dermatol 1996; 35: 1-13.

5. Shultz F et al. Atopic dermatitis: a genetic epidemiologic study in a population- based twin sample. J Am Acad Dermatol 1993; 28: 719-723

6. Dotterud LK et al. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger. Acta Der Venereol 1994; 74: 124-128

7. McNally NJ et al. The problem of atopic eczema: aetiological clues from the environment and life styles. Soc Sci Med 1998; 46: 729-741

8. Tatto MI et al. Prevalencia de asma, rinitis y eczema en escolares de la ciudad de Cuernavaca México. Salud Pública Mex 1997; 39: 497-506

9. Honeyman J et al. Dermatitis atópica II. Aspectos clínicos. Med Cutan Iber Lat Am 1998; 26: 1-30

10. Eigenmann P et al. Prevalence of IgE mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101: 1-6.

11. Ricci G et al. Mite allergy (Der p 1) levels in houses of children with atopic dermatitis: the relationship with allergometric tests. Br J Dermatol 1999; 140: 651-655

12. Williams H et al. Worldwide variations in he prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103: 125-138

13. Cáceres H et al. Dermatitis atópica en el Instituto de Salud del Niño. Dermatología Peruana Edición Especial Sep 1998; 64-5.

14. Tincopa O et al. Dermatitis atópica. Prevalencia en escolares de Trujillo con y sin antecedentes personales y/o familiares de atopía. Dermatología Peruana 1997; 7: 103-110

15. Rajka G. Essential aspects of atopic dermatitis. Berlin: Springer-Verlag: 1989

16. Leung D et al. Atopic dermatitis. In: Fitzpatrick T Dermatology in General Medicine. 4th ed: McGraw Hill 1993

17. Baer RL. Atopic dermatitis. Philadelphia: Lippincott: 1955

18. Beltrani VS. The clinical spectrum of atopic dermatitis. J Allergy Clin Immunol 1999; 104: S87-S98

19. Williams HC et al. The UK Working Party’s diagnostic criteria for atopic dermatitis: I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-396

20. Ebata T et al. Effects of nitrazepam on nocturnal scratching in adults with atopic dermatitis: a double blind placebo controlled crossover study. Br J Dermatol 1998; 136: 631-4.

21. Hägermark Ö et al. Itch in atopic dermatitis: the role of histamine and other mediators and the failure on antihistamine therapy. Dermatological Therapy 1996; 1: 75-82.

22. Hanifin JM et al. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 (suppl); 92: 44-47

23. Mevorah B. Marazzi A. Frenk E. The prevalence of accentuated palmoplantar markings and keratosis pilaris in atopic dermatitis, autosomal dominant ichthyosis and controls of dermatological patients. Br J Dermatol 1985; 112: 679-685

24. Kang K. Tian R. Atopic dermatitis -an evaluation of clinical and laboratory findings. Int J Dermatol 1987; 26:27-32

25. Williams HC. Pembroke AC. Infraorbital crease, ethnic group, and atopic dermatitis. Arch Dermatol. 1996; 132: 51-4.

26. Singh I. Kanwar AJ. Infraorbital crease and atopic dermatitis. Pediatr Dermatol. 1997; 14: 344-6.

27. J.D. Bos. Atopiforme dermatitis. Br J Dermatol 2002:147;426-429.

28. Lever R. Turbit M. Sanderson A et al. Immunophenotyping of cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987; 89:4-7

29. Feingold S. Huang C. Kristal L et al. Eczemas. Curr Probl Dermatol 1998; 10:41-92

30. Rothemberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-1600

31. Czech W. Krutmann J. Schopf E et al. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992; 126:351-355.

32. Hanifin JM. Dermatitis atópica en lactantes y niños. Clínicas Pediátricas NA 1991; 4:785-814

33. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999; 104:S99-108.

34. Hanifin J. Chan S. Biochemical and immunologic mechanisms in atopic dermatitis: New targets for emerging therapies J Am Acad Dermatol 1999, 41:72-7.

35. Holden CA. Chan SC. Hanifin JM. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis. J Invest Dermatol 1986; 87:372-376

36. Leyden JE. Marples RR. Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525-530

37. Hauser C. Wuethrich B. Matter L et al. Staphylococcus aureus skin colonization in atopic dermatitis. Dermatologica 1985; 170:35-39

38. Abeck D. Strom K. Optimal management of atopic dermatitis. Am J Clin Dermatol 2000; 1:41-46

39. Panconesi E y Houtmann G. Aspectos psicofisiológicos del estrés en dermatología: Patrón psicobiológico de los aspectos psicosomáticos. Clínicas Dermatológicas NA 1996; 3:413-435

40. Isolauri E. Tahvanainen A. Peltola T et al. Breast feeding of allergic infants J Pediatr 1999; 134:27-32

41. Jong M. Sharp V et al. Randomized controlled trial of brief neonatal exposure to cows milk on the development of atopy Arch Dis Child 1998; 79:126-130

42. Ricci G. Patrizi A. Specchia F et al. Mite allergen (Der p 1) levels in houses of children with atopic dermatitis: the relationship with allergometric tests. Br J Dermatol 1999; 140: 651-655

43. Cameron MM. Can house dust mite-triggered atopic dermatitis be alleviated using acaricides? Br J Dermatol 1997; 137: 1-8

44. Schachner L. Field T. Hernandez-Reif M et al. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol 1998; 15: 390-398

45. McFadden JP. Noble WC. Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631-632

46. Hanifin J. Tofte S. Update on therapy of atopic dermatitis. J Allergy Clin Immunol 1999; 104: S123-S125

47. Lucky AW. Leach AD. Laskarzewski P et al. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324.

48. Long CC. Mills CM. Finlay AY. A practical guide to topical therapy in children. Br J Dermatol 1998; 138: 293-296.

49. Simons FE. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC study group. Early treatment of the atopic child. J Allergy Clin Immunol 1999; 104:433-440.

50. Galli E. Chini L. Moschese V et al. Methylprednisolone bolus: a novel therapy for severe atopic dermatitis. Acta Pediatr.1994; 83: 315-17.

51. Neuber K. Dieck A. Itscert G et al. Therapie des schweren atopischen Ekzems mit Mycophenolatmofetil (CellCept®). Hautarzt 1999; 50: S109

52. Honeyman J. Manejo de la atopía cutánea. Dermatología Peruana 2001; 11

53. Torphy TJ. Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46: 512-523.

54. Grundmann-Kollmann M. et al Mycophenolate Mofetil Is Effective in the Treatment of Atopic Dermatitis.Arch Dermatol 137,870-873,2001.

55. Kaplan RJ. Daman L. Rosenberg E et al. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Arch Dermatol 1978; 114: 60-62.

56. Hanifin JM. Chan SC. Cheng JB et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996; 107: 51-56.

57. Stevens SR. Hanifin JM. Hamilton T et al. Long term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 1998; 134: 799-804.

58. Ruzicka T. Bieber T. Schopf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-821.

59. Boguniewicz M. Fiedler VC. Raimer S et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998; 102: 637-644.

60. Charles L. Pharm D Drug Information Handbook-Up to Date 10.2; 2002.

61. Van-Leent EJ. Graber M. Thurston M et al. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998; 134: 805-9.

62. Burtin P. Thomas M. Green A et al. First experience of topical SDZ ASM 981 in children with atopic dermatitis. 

63. 57th Meeting of the American Academy of Dermatology Poster exhibition. New Orleans, March 2002.


Regresar al artículo

 


back.gif (71 bytes) Contenido

Volumenes anteriores

Listado por Títulos